불임 치료 시장 규모, 점유율, 성장 분석 : 제품별, 시술별, 환자 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Infertility Treatment Market size was valued at USD 4.06 Billion in 2024 and is poised to grow from USD 4.34 Billion in 2025 to USD 7.41 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global infertility treatment market is witnessing significant growth driven by several key factors, including rising infertility rates, advancing maternal age, lifestyle changes, and breakthrough medical technologies. A substantial portion of the global population experiences infertility, fueling the demand for effective and innovative treatment solutions. Assisted Reproductive Technology (ART) methods, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have emerged as mainstream options, benefiting from continuous technological advancements that enhance success rates and patient outcomes. This market is poised for further expansion as these technologies become more accessible and affordable. Factors like the increasing acceptance of third-party reproduction, growing disposable income, and trends toward delayed parenthood also contribute to the evolving landscape of infertility treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segments Analysis

Global Infertility Treatment Market is segmented by Product, Procedure, Patient Type, End User and region. Based on Product, the market is segmented into Equipment, Media & Consumables and Accessories. Based on Procedure, the market is segmented into Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries and Other Infertility Treatment Procedures. Based on Patient Type, the market is segmented into Female Infertility Treatment and Male Infertility Treatment. Based on End User, the market is segmented into Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infertility Treatment Market

The increasing prevalence of infertility on a global scale can be attributed to factors such as lifestyle changes, postponed parenthood, and environmental influences. This rise in the number of individuals and couples facing fertility challenges has led to a growing demand for a variety of infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have markedly improved success rates, thereby making these treatments more effective and accessible. Collectively, these elements are driving the growth of the infertility treatment market.

Restraints in the Infertility Treatment Market

A significant challenge facing the infertility treatment market is the high cost associated with advanced therapies like in vitro fertilization (IVF) and genetic testing. These financial burdens limit access for many individuals, making it difficult for a large segment of the population to afford these essential treatments. In addition, ethical dilemmas surrounding assisted reproductive technologies-such as concerns over embryo manipulation and the moral considerations of surrogacy-add layers of complexity that can hinder market expansion. These factors contribute to a constrained environment, affecting both the accessibility of services and overall growth within the sector.

Market Trends of the Infertility Treatment Market

The infertility treatment market is experiencing significant growth driven by rising consumer awareness and an increased emphasis on precision medicine, particularly in in vitro fertilization (IVF) techniques. Genetic testing and screening innovations are becoming essential, facilitating more personalized embryo selection that enhances the chances of successful implantation while minimizing genetic risks. Additionally, there is a notable trend towards the acceptance and utilization of third-party reproductive methods, such as surrogacy and gamete donation, which are gaining traction among individuals and couples navigating infertility challenges. This evolving landscape reflects a broader societal willingness to explore diverse pathways to parenthood, ultimately shaping the future of infertility treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis

Global Infertility Treatment Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

Global Infertility Treatment Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Assisted Reproductive Technology
  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction
  • Vasovasostomy
  • Vasoepididymostomy
• Other Infertility Treatment Procedures

Global Infertility Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Female Infertility Treatment
• Male Infertility Treatment

Global Infertility Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

Global Infertility Treatment Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Patient Type, End User)
  • US
  • Canada
• Europe (Product, Procedure, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure, Patient Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Biomedx (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indira IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theralogix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zita West (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations